NUS — NU Skin Enterprises Income Statement
0.000.00%
- $419.18m
- $409.88m
- $1.49bn
- 97
- 96
- 36
- 90
Annual income statement for NU Skin Enterprises, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,696 | 2,226 | 1,969 | 1,732 | 1,485 |
| Cost of Revenue | |||||
| Gross Profit | 2,020 | 1,595 | 1,357 | 1,182 | 1,031 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,462 | 2,115 | 1,921 | 1,884 | 1,243 |
| Operating Profit | 234 | 111 | 48.3 | -152 | 242 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 232 | 89 | 26.6 | -175 | 196 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 147 | 105 | 8.6 | -147 | 160 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 147 | 105 | 8.6 | -147 | 160 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 147 | 105 | 8.6 | -147 | 160 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.5 | 2.7 | 0.43 | -0.303 | 0.733 |
| Dividends per Share |